Wuhan Union Hospital, China: Neoplasms trials
The registry lists 10 Neoplasms studies with Wuhan Union Hospital, China as lead sponsor. 3 are open to participants now and 0 have results posted.
Early Phase 1 2Phase 1 4Phase 2 2No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell MalignanciesRecruitingNCT06732492Phase 1
- Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular CarcinomaRecruitingNCT06383520Early Phase 1
- Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid TumorsNot yet recruitingNCT05527821Phase 2
- Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic MalignanciesStatus unknownNCT05672420Phase 1/2
- 68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors PatientsStatus unknownNCT05490849Early Phase 1
- Safety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRCStatus unknownNCT05155124Phase 1
- Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular CarcinomaStatus unknownNCT05006326Not applicable
- Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant TumorsStatus unknownNCT04554719Not applicable
- Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte MalignanciesStatus unknownNCT04008394Phase 1
- Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer DiagnosisCompletedNCT03830619